2015
DOI: 10.1681/asn.2013060577
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Intracellular Clusterin Attenuates Cell Death in Nephropathic Cystinosis

Abstract: Nephropathic cystinosis, characterized by accumulation of cystine in the lysosomes, is caused by mutations in CTNS. The molecular and cellular mechanisms underlying proximal tubular dysfunction and progressive renal failure in nephropathic cystinosis are largely unclear, and increasing evidence supports the notion that cystine accumulation alone is not responsible for the end organ injury in cystinosis. We previously identified clusterin as potentially involved in nephropathic cystinosis. Here, we studied the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
30
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 37 publications
(32 citation statements)
references
References 55 publications
(69 reference statements)
1
30
0
Order By: Relevance
“…21,22,28 In this context, it is important to note that recent advances in the field of cystinosis have highlighted that aberrant autophagy is an important contributor to the pathogenesis of the disease. 10,29 The discovery of compounds, such as genistein 23 and 2-hydroxypropyl-b-cyclodextrin, 30 able to stimulate endogenous TFEB activity has provided an attractive alternative to gene-transfer therapy in the treatments of diseases that potentially can benefit from TFEB activation. Genistein, a natural isoflavone present in soy, has been proposed as therapeutic agent for the LSD, mucopolysaccharidosis, for its ability to inhibit the synthesis and reduce lysosomal storage of glycosaminoglycans 31 and, recently, for its ability to activate TFEB.…”
Section: Discussionmentioning
confidence: 99%
“…21,22,28 In this context, it is important to note that recent advances in the field of cystinosis have highlighted that aberrant autophagy is an important contributor to the pathogenesis of the disease. 10,29 The discovery of compounds, such as genistein 23 and 2-hydroxypropyl-b-cyclodextrin, 30 able to stimulate endogenous TFEB activity has provided an attractive alternative to gene-transfer therapy in the treatments of diseases that potentially can benefit from TFEB activation. Genistein, a natural isoflavone present in soy, has been proposed as therapeutic agent for the LSD, mucopolysaccharidosis, for its ability to inhibit the synthesis and reduce lysosomal storage of glycosaminoglycans 31 and, recently, for its ability to activate TFEB.…”
Section: Discussionmentioning
confidence: 99%
“…This protein was shown to be involved in induction of apoptosis in RPTECs (Sansanwal et al, 2015). Silencing of this gene causes inhibition of apoptosis, indicating that clusterin plays a crucial role in the renal cell injury mechanism (Sansanwal et al, 2015). Among downregulated genes in cells treated with AmB-Cu 2+ complexes were also two genes that were upregulated in cells treated with AmB: STC2 and SOD2.…”
Section: Discussionmentioning
confidence: 99%
“…Studies using a cystinotic mouse model have shown decreased expression of the multi-ligand receptors megalin and cubilin in proximal tubules; this was associated with cell dedifferentiation and apoptosis (5,8). Also, enhanced cell death due to activation of proapoptotic signals probably occurs in other tissues (9)(10)(11).…”
mentioning
confidence: 99%